Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage

Stroke

Volumn 42, Issue 12, 2011, Pages 3624-3627

  Chou, Sherry H Y ^a   Lee, Po Shun ^b   Konigsberg, Rachael G ^a   Gallacci, Dana ^b   Chiou, Terry ^b   Arai, Ken ^a   Simmons, Suzanne ^a   Bauer, David ^a   Feske, Steven K ^a   Lo, Eng H ^a   Ning, Mingming ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Biomarker; Gelsolin; Matrix metalloproteinases; Subarachnoid hemorrhage

Indexed keywords

GELATINASE A; GELATINASE B; GELSOLIN;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; SUBARACHNOID HEMORRHAGE; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GELSOLIN; HUMANS; HYDROCEPHALUS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; SUBARACHNOID HEMORRHAGE;

EID: 83355165637     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.631135     Document Type: Article

References (12)

1. Sercombe R, Dinh YR, Gomis P. Cerebrovascular inflammation following subarachnoid hemorrhage. Jpn J Pharmacol. 2002;88:227-249. (Pubitemid 34302973)
2. Li GH, Arora PD, Chen Y, McCulloch CA, Liu P. Multifunctional roles of gelsolin in health and diseases. Med Res Rev. 2010 Nov. 9 [Epub ahead of print].
3. Endres M, Fink K, Zhu J, Stagliano NE, Bondada V, Geddes JW, et al. Neuroprotective effects of gelsolin during murine stroke. J Clin Invest. 1999;103:347-354. (Pubitemid 29069984)
4. Yildirim F, Gertz K, Kronenberg G, Harms C, Fink KB, Meisel A, et al. Inhibition of histone deacetylation protects wildtype but not gelsolindeficient mice from ischemic brain injury. Exp Neurol. 2008;210:531-542.
5. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One. 2008;3:e3712.
6. Lee PS, Drager LR, Stossel TP, Moore FD, Rogers SO. Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients. Ann Surg. 2006;243:399-403. (Pubitemid 43327773)
7. Kulakowska A, Ciccarelli NJ, Wen Q, Mroczko B, Drozdowski W, Szmitkowski M, et al. Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurol. 2010;10:107.
8. Park SM, Hwang IK, Kim SY, Lee SJ, Park KS, Lee ST. Characterization of plasma gelsolin as a substrate for matrix metalloproteinases. Proteomics. 2006;6:1192-1199.
9. Chou SH-Y, Ning MM, Konigsberg RG, Loesch EC, Alpargu G, Chibnik L, De Jager PH, Feske SK, Lo EH. Peripheral leukocyte count and matrix metalloproteinase-2 in cerebral vasospasm following subarachnoid hemorrhage. Neurology. 2010;74:A131.
10. Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G, et al. Proteomic investigations of the ventriculo-lumbar gradient in human CSF. J Neurosci Methods. 2010;191:244-248.
11. Guo ZD, Sun XC, Zhang JH. Mechanisms of early brain injury after SAH: matrix metalloproteinase 9. Acta Neurochir Suppl. 2011;110:63-65.
12. Zhou Y, Martin RD, Zhang JH. Advances in experimental subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;110:15-21.